Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SYHA 1402

Next Previous
X
Search
Drug Profile

SYHA 1402

Alternative Names: SYHA-1402

Latest Information Update: 07 Jun 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator CSPC ZhongQi Pharmaceutical Technology
  • Class Neuroprotectants; Small molecules
  • Mechanism of Action Aldehyde reductase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Diabetic neuropathies

Most Recent Events

  • 07 Jun 2023 SYHA 1402 is still in phase I trials for Diabetic neuropathies (In volunteers) in China (PO) (CSPC Pharmaceutical Group pipeline)
  • 28 Dec 2022 No recent reports of development identified for phase-I development in Diabetic-neuropathies(In volunteers) in China (PO, Tablet)
  • 12 Nov 2021 CSPC ZhongQi Pharmaceutical Technology plans a phase II trial for Diabetic neuropathy in China (PO) in December 2021 (NCT05116111)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top